Cardiology AI

“Nearly 2/3 coronary angiograms are not followed by therapeutic procedures: the scanner with a prediction of the FFR will make it possible to reduce this rate of risky examinations for the patient.”

See beyond anatomy

AI-powered CCTA analysis supporting faster, more informed clinical decision-making — at the point of care, with no external core lab required.

<1 min

FFR-AI estimation

CAD-RADS

Automated classification

Flexible

Cloud or on-premise

CorEx is a standalone software AI solution for comprehensive Coronary CT Angiography (CCTA) analysis.

Point-of-care solution

Designed to integrate seamlessly into clinical workflows — bringing advanced analysis directly where care is delivered.

Why CorEx ?

Save time – Accelerate diagnosis with AI-automated interpretation

Save money – Reduce downstream costs and unnecessary procedures

Save lives – Support faster, better-informed clinical decisions

CAD RADS

CorEx automatically classifies lesions (stenoses) according to the international CAD-RADS classification, helping to choose optimal treatment for the patient.

FFRAI

CorEx provides an estimation of the Fractional Flow Reserve (FFR) in less than a minute. This analysis doesn’t require any core lab intervention. The measurement of FFR is used to determine the need for revascularization by stent or bypass. This analysis helps to reduce diagnostic ICA numbers by increasing cardiologists and radiologists confidence in their diagnostic.

What CorEx Changes for Your Cardiology Department

Chest pain triage

Support rapid, evidence-based decisions for patients presenting with chest pain and an initial CCTA.

Reducing unnecessary catheterization

FFR-AI estimation helps identify which patients are likely to benefit from invasive angiography.

Standardized reporting

Automated CAD-RADS classification supports consistent, guideline-aligned reporting across radiologists.

Regulatory & Quality

EU-Wide Availability:

Our products now meet EU safety and health standards, making them available for use across the entire European Union!

Uncompromising Quality:

We design, develop, manufacture, and deliver medical devices that meet the highest standards of patient and healthcare professional needs, while complying with international regulations.

Data Protection and Cybersecurity:

We respect and comply with GDPR regulations, ensuring the confidentiality, integrity, and availability of your data. Our systems also meet international cybersecurity standards, protecting you from potential threats.

Our commitment to excellence extends beyond our products. We’re dedicated to providing you with:

World-Class Support:

Our team is always available to assist you with any questions or concerns you may have.

Continuous Innovation:

We’re constantly striving to improve and expand our product line, ensuring that you have access to the latest technology and advancements.

Want to know more ?

CorEx, by Spimed‑AI

The AI software that powers the Cardiology AI solution on this page.

CorEx is a CE‑marked, deep‑learning software solution built specifically to read coronary CT angiography (CCTA) exams. It is developed by Spimed‑AI, a medical‑imaging AI company founded in Paris, France in 2019.

The software automatically detects and grades coronary artery narrowing using the international CAD‑RADS classification, and estimates fractional flow reserve (FFR) for each vessel at the clinically significant 0.80 threshold — giving cardiologists a fast, standardized, point‑of‑care read without an invasive procedure.

Manufacturer

Spimed‑AI (Paris, France)

Founded

2019

Modality

Cardiac CT (CCTA)

Core Output

CAD‑RADS + FFR‑AI

Regulatory

CE Marked (Class I MDD)

One CCTA. Anatomical + functional insight. Minutes, not days.

CorEx brings AI-powered coronary assessment directly to the point of care, helping clinicians move from imaging to confident next-step decisions faster.

Customer experience

Hear from healthcare professionals and partners who have experienced the value of our innovative technology, clinical expertise, and dedicated support. Their feedback reflects our commitment to delivering solutions that make a meaningful difference in modern healthcare.

“With Subtle Medical, we were able to achieve the same high quality images with a 33% reduction in FDG dose. This had a positive impact on patient safety and the operational workflow too. Following the successful project in Italy, we decided to deploy the innovative solution across Afidea Europe, where we have an extensive volume of PET/CT units.”

Alessandro Roncacci, MD Chief Medical Officer Affidea (Turin, Italy)

We are excited about the results we have seen with SubtleMR. In our multicenter, multireader clinical validation Research, we reduce our image acquisition time by ~60% and were able to restore excellent image quality which exceeded that of standard-of-care. As we have begun incorporating SubtleMR into our routine clinical practice at some of our sites, we have found that image enhancement of our accelerated image protocols not only improves efficiency and boosts quality, but ultimately provides a better imaging experience for our patients.

Suzie Bash, MD Neuroradiologist at RadNet

Our goal at Precision Imaging Centers is to deliver the best patient care possible. We pride ourselves on being early adopters of innovative technology, which differentiates us from other imaging centers. Using SubtlePET, we are able to maintain superior image quality of our accelerated protocols. It also allows us to complete more CT's on the same scanner. The ability to conduct these faster scans both increases our workflow efficiency and creates a better patient experience by getting patients in and out of the scanner faster. It's a win-win for us and for them.

Adam Brochert Radiologist, Precision Imaging Centers